surpass 1 tirzepatide Once-weekly versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial A Study of Tirzepatide (LY3298176)

Learn More About Weight Loss Want to dig deeper into weight loss in a way that feels useful, not overwhelming

Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RHM, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al

Alexis Pedrick: There was another amphetamine derivative weight loss drug called Redux that was supposed to be safer than Fen Phen, but this turned out to not be the case

Most people begin to notice reduced appetite within the first 1-2 weeks and visible weight loss by weeks 8-12

Avoid irritated or scarred areas : Only inject into healthy, intact skin

Integrated Support: Care may align with hormone optimization and metabolic services for people of all genders